300
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The MOLES system to guide the management of melanocytic choroidal tumours: can optometrists apply it?

ORCID Icon, , , ORCID Icon, ORCID Icon &
Pages 271-275 | Received 16 Nov 2021, Accepted 04 Jan 2022, Published online: 13 Feb 2022

References

  • Qiu M, Shields CL. Choroidal nevus in the United States adult population: racial disparities and associated factors in the national health and nutrition examination survey. Ophthalmology. 2015;122:2071–2083.
  • Sumich P, Mitchell P, Wang JJ. choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophtalmol. 1998;116:645–650.
  • Vajdic CM, Kricker A, Giblin M, et al. Incidence of ocular melanoma in Australia from 1990 to 1998. Int J Cancer. 2003;105:117–122.
  • Keenan TD, Yeates D, Goldacre MJ. Uveal melanoma in England: trends over time and geographical variation. Br J Ophthalmol. 2012;96:1415–1419.
  • Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651–4659.
  • Burr JM, Mitry E, Rachet B, et al. Survival from uveal melanoma in England and Wales 1986 to 2001. Ophthalmic Epidemiol. 2007;14:3–8.
  • Damato BE, Heimann H, Kalirai H, et al. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol. 2014;132:605–613.
  • Khan J, Damato BE. Accuracy of choroidal melanoma diagnosis by general ophthalmologists: a prospective study. Eye (Lond). 2007;21:595–597.
  • Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients. Ophthalmology. 2012;119:1582–1589.
  • Damato B. Time to treatment of uveal melanoma in the United Kingdom. Eye (Lond). 2001;15:155–158.
  • Shields CL, Dalvin LA, Ancona-Lezama D, et al. Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and Victor T. Curtin Lecture. Retina. 2019;39:1840–1851.
  • Roelofs K, Weis E. Tele-Oncology: a validation study of choroidal and iris nevi. Ocul Oncol Pathol. 2019;5:298–302.
  • Roelofs KA, O’Day R, and Harby LA, et al. The MOLES System for planning management of melanocytic choroidal tumors: is it safe? Cancers (Basel). 2020;12:1311.
  • Roelofs KA, O’Day R, Al Harby L, et al. Detecting progression of melanocytic choroidal tumors by sequential imaging: is ultrasonography necessary? Cancers (Basel). 2020;12:1856.
  • Salehi O, van Wijngaarden P, and Keel S, et al. Estimating malignancy risk of melanocytic choroidal tumours detected in the Australian National Eye Health Survey. Clin Exp Optometry. 2021;104:854–858.
  • Al Harby L, Sagoo MS, and O’Day R, et al. Distinguishing choroidal nevi from melanomas using the MOLES algorithm: evaluation in an ocular nevus clinic. Ocul Oncol Pathol. 2021:7:294-302.
  • Kiely PM, Cappuccio S, McIntyre E. Optometry Australia scope of practice survey 2015. Clin Exp Optom. 2017;100:260–269.
  • Hemmerdinger C, Beech M, Groenewald C, et al. Validation of an online referral guide for melanocytic fundus lesions. Ophthalmic Physiol Opt. 2011;31:574–579.
  • Al Harby L, Ali Z, and Rajai A, et al. Prospective validation of a virtual clinic pathway in the management of choroidal naevi: the NAEVUS study Report no. 1: safety assessment. Br J Ophthalmol. 2020;106:128-134.
  • LLC CND. Eye handbook. Apple App Store. Kansas, US; 2021. p iPadOS 12.10; iOS 12.10.
  • LLC CND. Eye handbook. Google Play App Store. Kansas, US; 2021. p Android 4.2.
  • Zarwell T. EyeDock. Apple App Store. Wisconsin, US; 2021. p iOS 6.0

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.